Approved Study Database

Ref. No. Scientific Title Principal investigator
2007.472 International, Multi-Center, Randomized, Double Blind Study to Compare the Overall Mortality in Acutely Ill Medical Patients Treated with Enoxaparin versus Placebo in Addition to Graduated Elastic Stockings Professor Cheng Gregory
2008.513 An International, Multicenter, Randomized, Double-blind Study of Vorinostat (MK-0683) or Placebo in Combination with Bortezomib in Patients with Multiple Myeloma Prof Cheng Gregory
2009.186 A Phase I/IIa Safety and Pharmacokinetic Study of Intravenous FIXFc Administration to Previously Treated Hemophilia B Patients Prof. Cheng Gregory
2021.380 Resting and Dynamic Right Ventricular-Pulmonary Arterial Coupling in Childhood Cancer Survivors Dr. CHENG Frankie Wai Tsoi
鄭偉才
2015.413 Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age-and body weight-adjusted rivaroxaban regimen compared to standard of care in children with acute venous thromboembolism Dr. CHENG Frankie Wai Tsoi
2017.371 TREATMENT OUTCOME OF HEPATOBLASTOMA AND PAEDIATRIC HEPATOCELLULAR CARCINOMA IN HONG KONG Dr. CHENG Frankie Wai Tsoi
2015.553 Intergroup trial for children or adolescents with B-cell NHL or B-AL: Evaluation of Rituximab efficacy and safety in high risk patients Dr. CHENG Frankie Wai Tsoi
鄭偉才醫生
2011.190 Monitoring of Epstein-Barr virus (EBV) viral load and its impact on post-transplant lymphoproliferative disease (PTLD) in paediatrc haematopoieitic stem cell transplant recipients Dr. Cheng Frankie Wai Tsoi
2009.471 Humoral Response of Pandemic (H1N1) Influenza Vaccination in Paediatric Oncology and Stem Cell Transplant Patients Dr. Cheng Frankie Wai Tsoi
2009.192 Humoral Response of Pneumococcal Vaccination in Paediatric Oncology Patients Dr. Cheng Frankie Wai Tsoi
2020.246 Outcome of Paediatric Chronic Myeloid Leukemia in Hong Kong Dr. CHENG Frankie Wai Tsoi
2013.375 Pathophysiology of oropharyngeal dysphagia in post-irradiation nasopharyngeal carcinoma patients in relation to penetration-aspiration - A pilot study Mr CHENG Dennis Tze-ho
2026.153 Implementation of Digital Nursing Handover Practice in PWH – Private Ward: Evidenced Based Practice approach to enhance Handover efficiency and staff satisfaction Ms. Cheng Chun Chun
2011.133 A Traditional Chinese medicine formula for bones and joints care for chronic pain of lower limb: A Randomized Control Trial Prof Cheng Christopher Hon Ki
2014.677 A randomized controlled trial of power training with Thera-band and skipping rope to improve balance recovery for fall prevention Dr Cheng Chik Chi Kenneth
2026.552 The level of Knowledge, Attitude, and Practice of Healthcare Providers in Old Age Homes Towards Emergency Care and Resuscitation for Choking in Hong Kong: A cross-sectional survey Mr. CHENG Chi Ming
鄭智銘
2007.435 Comparison of Oral Prednisolone/Paracetamol and Oral Indomethacin / Paracetamol Combination Therapy in the Treatment of Acute Gout like Arthritis: A Multi-Centre, Double-Blind, Randomized, Controlled Trial Dr. Cheng Chi Hung
2008.466 Comparison of Oral Prednisolone and Oral Indomethacin in the Treatment of Acute Gout-like Arthritis: A Multi-centre, Double-Blind, Randomized Trial Dr. Cheng Chi Hung
2016.482 Functional genomic characterization of human placental development and pathology for noninvasive biomarker discovery Dr. CHENG Alice Suk Hang
曾卓豪
2014.076 Mechanistic characterization of liver cancer epigenome mediated by androgen receptor signaling Dr. CHENG Alfred Sze Lok
2016.230 Co-targeting the AKT and EZH2 epigenetic pathways in hepatitis B virus-related hepatocellular carcinoma Prof. CHENG Alfred Sze Lok
鄭詩樂
2015.187 Dissecting an inflarnmatory-CCRK circuitry m non-alcoholic fatty liver disease-related hepatocarcinogenesis Prof. CHENG Alfred Sze Lok
鄭詩樂
2023.105 The role of macrophage lipid transfer in driving immunotherapy resistance of hepatocellular carcinoma cells Prof. CHENG Alfred Sze Lok
2021.227 Advancing Precision Immunotherapy of Hepatocellular Carcinoma by Single-cell Multi-Omics Prof. CHENG Alfred Sze Lok
鄭詩樂
2018.411 Deciphering Enhancer Regulation of Tumor Immune Evasion to Develop New Combination Immunotherapies Prof. CHENG Alfred Sze Lok
鄭詩樂
2018.051 Functional dissection of fibrosis-associated monocytic myeloid derived suppressor cells (M-MDSCs) in hepatocellular carcinoma Prof. CHENG Alfred Sze Lok
鄭詩樂
2018.576 Molecular and functional characterization of the immunoregulatory CCRK-mTOR pathway in NAFLD-associated hepatocellular carcinoma Prof. CHENG Alfred Sze Lok
鄭詩樂
2019.276 To develop an evidence-based training programme for improving infection control knowledge and skills related to multi-drug resistance organisms (MDROs) transmission during enteral feeding among hospital nurses. Miss CHENG Wai Yan
鄭慧恩
2020.001 Genomic and Functional Characterization of Oral Microbiome Associated with Head and Neck Squamous Cell Carcinoma Prof. CHEN Zigui
陳子桂
2019.036 Dissecting the role of Fusobacterium nucleatum in head and neck squamous cell carcinoma by genomics and functional approaches Prof. CHEN Zigui
陳子桂
2018.022 Structure and diversity of gastrointestinal (oral and stool) microbial communities of companion animals impacting on human counterparts Prof. CHEN Zigui
陳子桂
2021.681 Origin and evolutionary adaptation of the carcinogenicity of human papillomaviruses: evaluation of human and non-human primate PV E6 and E7 oncogenes interacting with host proteomes Prof. CHEN Zigui
陳子桂
2020.705 Associations between human microbiome and host epigenetic and genetic events in esophageal squamous cell carcinoma (ESCC) using multi-omics approaches Prof. CHEN Zigui
陳 子 桂
2021.671 Characterization of Genomic and Functional Features of Human Microbiome Associated with Oral Cavity Squamous Cell Carcinoma using Multi-Omics Approaches Prof. CHEN Zigui
陳子桂
2022.553 Genetic and Epigenetic Abnormalities Associated with Dysbiosis of the Human Microbiota in Esophageal Squamous Cell Carcinoma (ESCC) Prof. CHEN Zigui
陳子桂
2022.554 Host-Microbiota Interactions Related to HPV(+) and HPV(-) Oropharyngeal Squamous Cell Carcinoma (OPSCC) Prof. CHEN Zigui
陳子桂
2017.143 Association between oral microbiome, HPV and human epigenetic events in head and neck squamous cell carcinoma Prof. CHEN Zigui
2016.186 Evolutionary dynamics and genetic basis of carcinogenicity of primate papillomaviruses Prof. CHEN Zigui
2026.006 Understanding Microbiota-Guided Remodeling of OSCC Immune Microenvironment: from Dysbiosis to ICI Sensitization Prof. CHEN Zigui
2025.016 Unravelling the Impact of Oral Microbiota Dysbiosis and HPV on Genomic Architecture and Tumor-Associated Immune System in Oropharyngeal Squamous Cell Carcinoma (OPSCC) Prof. CHEN Zigui
陳子桂
2023.637 Understanding the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Oral Cavity Squamous Cell Carcinoma (OSCC) through Dysregulation of Epithelial-Mesenchymal Transition (EMT)-related Pathways Prof. CHEN Zigui
陳子桂
2025.683 Unravelling the crosstalk between oral microbiota dysbiosis and immune checkpoint dysregulation in head and neck squamous cell carcinoma (HNSCC) patients: towards personalized immunotherapy Prof. Chen Zigui
2025.677 微生物菌群调控食管鳞状细胞癌免疫治疗的增敏机制与转化研究 (Mechanism and Application of Microbiota-Modulated Immunotherapy for Esophageal Squamous Cell Carcinoma (ESCC)) Prof. CHEN Zigui
2016.556 Quantification of breast milk trans fatty acids and trans fat intake by Hong Kong lactating women Dr. CHEN Zhen Yu
陳振宇
2023.673 Effect of A Self-Regulation Promoting Education Program on Adherence to Oral Anticancer Agents among Patients with Gastrointestinal Tract Cancer: A Randomized Controlled Trial Ms. CHEN Yongfeng
陈永凤
2021.508 The investigation of anti-tumor activity of novel bispecific antibodies against solid tumors Dr. CHEN Yangchao
陳揚超
2010.196 Development of HPV therapeutic vaccine and related immunotherapy for treating cervical cancer DR Chen Yangchao
2018.124 Identification of novel therapeutic target kinase for KRAS mutant pancreatic ductal adenocarcinoma by kinome-wide RNAi screening Dr. CHEN Yangchao
陳揚超
2020.042 Elucidating the novel mechanisms of the oncogenic circRNA-DNA interactions and investigating their roles in pancreatic ductal adenocarcinoma Dr. CHEN Yangchao
陳揚超
2019.098 Characterization of the anti-metastatic function of POU4F3 in pancreatic ductal adenocarcinoma and delineate its underlying mechanisms Dr. CHEN Yangchao
陳揚超

Page 217 of 289.